DANBURY, Conn., Dec. 31 /PRNewswire-FirstCall/ -- Tasker Capital Corp. (OCT Bulletin Board: TKER), a distributor and marketer of a licensed proprietary technology that is highly effective in inhibiting pathogenic bacteria, today announced that it has decided not to enter into any definitive agreements regarding a previously announced $20 million line of credit in June 2004. After recently completing a private placement of its equity shares for gross proceeds of $15 million, management believes that the Company is sufficiently capitalized.
Bob Appleby, Tasker’s president and CEO, commented, “With nationwide distribution of Close Call(TM) scheduled for January, and the progress achieved on our discussions with poultry processors, worldwide, we hope the company will achieve a self-sustaining financial position reasonably soon. We feel that the private placement just completed is a more economically efficient source of working capital.”
About Tasker Products
Tasker Products is a manufacturer, distributor and marketer of products using a unique, licensed patented process that utilizes a highly charged, acidified, yet stable and safe solution that enables copper sulfate, widely known for its bacteriostatic properties to remain active throughout a wide range of pH values. The company is continuing its clinical research and development of future products in the oral care, food processing, skin care and pet products industries. Presently the company markets Close Call(TM), the world’s first clinically proven anti-microbial oral hygiene breath drink. Tasker Capital Corp. is headquartered in Danbury, Connecticut. To be added to the news distribution list, send an e-mail to tasker@wallstreetir.com.
This release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statement. Actual future results and trends may differ materially from those made in or suggested by any forward-looking statements due to a variety of factors, including, for example, our ability to compete with other products in our space; the risk of unfavorable federal regulation; and the fact that our status as a development stage company makes our future unclear. Consequently you should not place undue reliance on these forward-looking statements. We discuss many of these and other risks and uncertainties in greater detail under the section entitled, “Risk Factors That May Affect Future Results” in Item 1 of the Company’s Current Report on Form 10-KSB as filed with SEC.
Investor Contact: Joseph M. Zappulla Wall Street Investor Relations 212-681-4100 jzappulla@wallstreetir.com
Tasker Capital Corp.
CONTACT: Investor - Joseph M. Zappulla of Wall Street Investor Relations,+1-212-681-4100, jzappulla@wallstreetir.com, for Tasker Capital Corp.
Web site: http://www.breathrephresh.com/
